Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03424993 · ClinicalTrials.gov registry record · Phase 4

Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure

A Phase 4 study, sponsored by University of Delaware.

Completed
Registry status
Phase 4
Development phase
100
Enrollment target

NCT03424993: Completed Phase 4 study, sponsored by University of Delaware.

NCT03424993 is a Phase 4 study that has completed, run by University of Delaware. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03424993, a Phase 4 study, has completed, sponsored by University of Delaware.

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effects of dietary salt restriction on central hemodynamics and vascular function in men and women with salt resistant blood pressure.

Primary Outcome

Late systolic pulsatile load on the left ventricle represented by reflected pulse wave amplitude; assessed by echocardiography combined with applanation tonometry.

Interventions

  • OTHER Control
  • OTHER Dietary Sodium Restriction

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-01-21
Est. Completion 2024-06-10
Phase Phase 4
University of Delaware

106 total trials

What the finished NCT03424993 record still lists

NCT03424993 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT03424993 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03424993 about?

NCT03424993 is a clinical study titled "Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure". The purpose of this study is to determine the effects of dietary salt restriction on central hemodynamics and vascular function in men and women with salt resistant blood pressure.

What is the current status of trial NCT03424993?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2018-01-21. Estimated completion is 2024-06-10.

What interventions are being tested in trial NCT03424993?

The interventions under investigation include: Control (OTHER), Dietary Sodium Restriction (OTHER).

Who is sponsoring clinical trial NCT03424993?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03424993's enrollment target sits among peer trials

100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03424993, the US trial registry maintained by the National Library of Medicine. NCT03424993 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.